Table 5.
Subjective evaluation of included patients at follow-up period
| Scales | Preoperation | At follow-up | MD (95% CI) | P value |
|---|---|---|---|---|
| PFDI-20, mean ± SD | 78.72 ± 32.54 | 5.97 ± 11.02 | − 72.76 (− 78.97 to − 66.55) | < 0.001 |
| PFIQ-7, mean ± SD | 63.88 ± 31.03 | 0.76 ± 4.63 | − 63.12 (− 69.13 to − 57.11) | < 0.001 |
| PISQ-12, mean ± SD | 13.82 ± 14.73 | 19.59 ± 19.53 | 4.80 (2.01 to 7.58) | 0.0013 |
| PGI-C, n (%) | ||||
| Very much improved | – | 99 (93.40) | – | |
| Much improved | 6 (5.66) | |||
| Minimally improved | 1 (0.94) |
PFDI-20 Pelvic floor distress inventory-short form 20; PFIQ-7 Pelvic floor impact questionnaire short form 7; PISQ-12 Pelvic organ prolapse/urinary incontinence sexual questionnaire-12; PGI-C Patient global impression of improvement; MD Mean difference; CI Confidence interval